SMP is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The setup is mixed: the stock is trading below its recent pivot, momentum is weak, and there is no fresh news, analyst upgrade, or insider/catalyst support to justify an immediate long-term purchase. If the investor is impatient and wants to act now, this is better treated as a hold than a buy.
Current price is 37.75, slightly below the previous close of 37.93. The MACD histogram is -0.152 and still expanding negatively, which points to weakening short-term momentum. RSI_6 at 32.793 is near oversold but not yet a clear reversal signal. Moving averages are converging, suggesting indecision rather than a confirmed uptrend. Price is below the pivot at 39.164 and also below R1 at 40.287, while support sits at 38.041 and deeper support at 37.347. Overall, the technical trend is weak-to-neutral, with no confirmed buy signal.

["Low put-call open interest ratio of 0.23 suggests bullish positioning", "RSI is near oversold levels, which can support a rebound attempt", "Stock trend model indicates a positive short-term probability, including 1.23% over the next week and 15.96% over the next month"]
["No news in the recent week, so there is no event-driven catalyst", "MACD is negative and worsening, showing bearish momentum", "Price is below the pivot and close to support, indicating weak trend structure", "No AI Stock Picker signal today", "No SwingMax signal recently", "Hedge funds are neutral", "Insiders are neutral", "No recent congress trading data", "No analyst upgrade or positive rating trend provided"]
No usable latest-quarter financial snapshot was provided due to a data error, so I cannot confirm recent revenue or earnings growth trends. The latest quarter season is not available in the dataset. Based on the missing financials, there is no clear fundamental acceleration to support an immediate long-term buy decision.
No recent analyst rating or price target change trend was provided. That means Wall Street sentiment cannot be described as improving. With no visible upward revisions, the pros view is limited, while the cons view is that the stock lacks fresh analyst support and a clear catalyst.
